Latest Life Science Partners Stories
ZURICH, April 28, 2014 /PRNewswire/ -- Sequana Medical AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23 million ($26.2 million) in a Series C preferred share financing round led by LSP (Life Science Partners), and co-led by NeoMed Management, VI Partners, BioMedInvest, Entrepreneurs Fund and Capricorn Venture Partners. NeoMed retains its role as the largest investor in Sequana Medical....
- Exultant; jubilant; triumphant; on the high horse.
- Tipsy; slightly intoxicated.